This company has been marked as potentially delisted and may not be actively trading. Brickell Biotech (BBI) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Brickell Biotech Short Interest DataBrickell Biotech (BBI) has a short interest of 189,600 shares, representing 7.71% of the float (the number of shares available for trading by the public). This marks a 7.60% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 206,730 shares to cover all short positions.Current Short Interest189,600 sharesPrevious Short Interest176,200 sharesChange Vs. Previous Month+7.60%Dollar Volume Sold Short$663.60 thousandShort Interest Ratio0.7 Days to CoverLast Record DateAugust 15, 2022Outstanding Shares2,874,000 sharesFloat Size2,460,000 sharesShort Percent of Float7.71%Today's Trading Volume31,300 sharesAverage Trading Volume206,730 sharesToday's Volume Vs. Average15% Short Selling Brickell Biotech? Sign up to receive the latest short interest report for Brickell Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBBI Short Interest Over TimeBBI Days to Cover Over TimeBBI Percentage of Float Shorted Over Time Brickell Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2022189,600 shares $663.60 thousand +7.6%7.7%0.7 $3.50 7/31/2022176,200 shares $523.31 thousand -2.8%7.2%0.7 $2.97 7/15/2022181,300 shares $592.85 thousand +99.5%7.4%0.8 $3.27 6/30/202290,900 shares $515.40 thousand -98.1%3.7%0.4 $5.67 6/15/20224,880,000 shares $653.92 thousand +5.9%N/A0.9 $0.13 5/31/20224,610,000 shares $731.61 thousand -38.9%N/A0.8 $0.16 5/15/20227,550,000 shares $1.40 million +79.3%N/A1.4 $0.19 4/30/20224,210,000 shares $884.10 thousand +66.4%N/A0.8 $0.21 4/15/20222,530,000 shares $750.65 thousand -1.9%N/A0.5 $0.30 3/31/20222,580,000 shares $691.44 thousand No ChangeN/A0.3 $0.27 Get the Latest News and Ratings for BBI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brickell Biotech and its competitors with MarketBeat's FREE daily newsletter. 3/15/20222,580,000 shares $563.99 thousand +14.2%N/A0.3 $0.22 2/28/20222,260,000 shares $474.60 thousand -27.1%N/A0.3 $0.21 2/15/20223,100,000 shares $784.92 thousand +3.0%N/A0.4 $0.25 1/31/20223,010,000 shares $655.88 thousand +60.1%N/A0.4 $0.22 1/15/20221,880,000 shares $391.23 thousand +40.3%N/A0.3 $0.21 12/31/20211,340,000 shares $306.73 thousand -29.1%N/A0.5 $0.23 12/15/20211,890,000 shares $541.11 thousand +39.0%N/A0.7 $0.29 11/30/20211,360,000 shares $418.88 thousand -12.3%N/A0.6 $0.31 11/15/20211,550,000 shares $581.25 thousand -61.1%N/A0.7 $0.38 10/29/20213,980,000 shares $1.57 million +43.7%N/A2 $0.40 10/15/20212,770,000 shares $1.59 million +9.1%N/A2.5 $0.58 9/30/20212,540,000 shares $1.83 million -2.3%N/A2 $0.72 9/15/20212,600,000 shares $1.98 million +2.4%N/A2.3 $0.76 8/31/20212,540,000 shares $1.88 million -7.0%N/A2.2 $0.74 8/13/20212,730,000 shares $1.78 million -6.8%N/A2.3 $0.65 7/30/20212,930,000 shares $2.02 million -29.1%N/A2.4 $0.69 7/15/20214,130,000 shares $3.19 million -2.4%N/A3.3 $0.77 6/30/20214,230,000 shares $4.02 million +3.9%6.6%3.5 $0.95 6/15/20214,070,000 shares $3.49 million No Change6.3%4 $0.86 5/28/20214,070,000 shares $3.32 million -1.2%6.3%3.1 $0.82 5/14/20214,120,000 shares $3.50 million +0.2%6.4%2.6 $0.85 4/30/20214,110,000 shares $4.32 million -8.7%6.4%1.7 $1.05 4/15/20214,500,000 shares $3.96 million -1.3%7.0%1.6 $0.88 3/31/20214,560,000 shares $5.06 million +4.6%7.2%1.4 $1.11 3/15/20214,360,000 shares $4.93 million -4.8%6.8%1.1 $1.13 2/26/20214,580,000 shares $5.45 million -0.7%9.0%1.2 $1.19 2/12/20214,610,000 shares $7.47 million -8.9%9.0%1.2 $1.62 1/29/20215,060,000 shares $5.41 million +20.8%9.9%1.4 $1.07 1/15/20214,190,000 shares $4.61 million No Change8.2%1.2 $1.10 9/15/2020167,800 shares $135.73 thousand +35.4%N/A0.1 $0.81Out of 18,347 Cryptocurrencies... This is the ONLY One (Ad)The $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol quietly prints $1 million in fees every single day.Discover our #1 crypto recommendation here now >> 8/31/2020123,900 shares $116.47 thousand +65.4%N/A0 $0.94 BBI Short Interest - Frequently Asked Questions What is Brickell Biotech's current short interest? Short interest is the volume of Brickell Biotech shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 189,600 shares of BBI short. 7.71% of Brickell Biotech's shares are currently sold short. Learn More on Brickell Biotech's current short interest. What is a good short interest ratio for Brickell Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BBI shares currently have a short interest ratio of 1.0. Learn More on Brickell Biotech's short interest ratio. What is a good short interest percentage for Brickell Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.71% of Brickell Biotech's floating shares are currently sold short. Is Brickell Biotech's short interest increasing or decreasing? Brickell Biotech saw a increase in short interest in August. As of August 15th, there was short interest totaling 189,600 shares, an increase of 7.6% from the previous total of 176,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Brickell Biotech's float size? Brickell Biotech currently has issued a total of 2,874,000 shares. Some of Brickell Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Brickell Biotech currently has a public float of 2,460,000 shares. How does Brickell Biotech's short interest compare to its competitors? 7.71% of Brickell Biotech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Brickell Biotech: Finch Therapeutics Group, Inc. (0.01%), Calidi Biotherapeutics, Inc. (24.18%), AlloVir, Inc. (2.56%), NKGen Biotech, Inc. (1.86%), AIM ImmunoTech Inc. (414.92%), Sorrento Therapeutics, Inc. (0.65%), Genocea Biosciences, Inc. (0.33%), Eloxx Pharmaceuticals, Inc. (0.08%), Prime Medicine, Inc. (34.17%), Protalix BioTherapeutics, Inc. (5.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($4.13 billion), Charter Communications, Inc. ($3.94 billion), Coinbase Global, Inc. ($2.38 billion), Lucid Group, Inc. ($2.30 billion), T. Rowe Price Group, Inc. ($2.22 billion), Williams-Sonoma, Inc. ($2.02 billion), Plug Power, Inc. ($1.94 billion), Chesapeake Energy Co. ($1.91 billion), Unity Software Inc. ($1.82 billion), and Rivian Automotive, Inc. ($1.74 billion). View all of the most shorted stocks. What does it mean to sell short Brickell Biotech stock? Short selling BBI is an investing strategy that aims to generate trading profit from Brickell Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Brickell Biotech? A short squeeze for Brickell Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BBI, which in turn drives the price of the stock up even further. How often is Brickell Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBI, twice per month. The most recent reporting period available is August, 15 2022. More Short Interest Resources from MarketBeat Related Companies FNCH Short Interest CLDI Short Interest ALVR Short Interest NKGN Short Interest AIM Short Interest SRNE Short Interest GNCAQ Short Interest ELOX Short Interest PRME Short Interest PLX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BBI) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brickell Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brickell Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.